Most Popular
Sign Up Now!
First Name
Last Name
Email Address

China Strategy


Miracle is a strong word, but it’s the right word to describe what’s happening today in China. As this once-great land modernizes and shifts to a market-driven economy, the staggering economic growth taking place there will continue for the foreseeable future. The profit potential for investors who truly understand what’s happening inside China is equally staggering.

That’s why Robert Hsu made it his mission to help you profit from China’s economic miracle. In his China Strategy service, you’ll receive a monthly issue, weekly updates and Flash Alerts to keep you abreast of everything that’s happening in domestic and foreign markets. With this service, Robert will help you profit by bringing you the real China—the China that he knows first hand by reading Chinese newspapers, visiting the country, and his on-the-ground network of analysts. He’ll also protect you from the risks that cost many unwary investors dearly, by providing you with specific buy and sell advice on only the best-positioned companies set to profit from the China Miracle.

Login China Strategy Here —OR— Subscribe to China Strategy Now!

China Strategy's 2007 Performance

China Strategy Beat the S&P 10-to-1!

Company Gain Time Held
China Aluminum 285% 15 Months
Apple 118% 26 Months
Sinopec 58% 21 Months
Las Vegas Sands 52% 16 Months
Phelps Dodge 49% 6 Months
MS China Fund 24% 9 Months
Rio Tinto 21% 14 Months
Suntech Power 18% 13 Months
This Week in China Strategy

Gold Frenzy -- More Upside From Here?

Gold prices are high. In fact, they're at record heights -- and the question is, where will gold go from here? Well, to put it simply, gold will continue moving higher for the near term. While there will be pullbacks, they represent buying opportunities rather than the end of the gold bull market. A combination of strong demand from China and continued weakness in the dollar will continue to drive commodity prices higher -- especially gold. more...

Vroooom! China's Auto Market Racing Forward

China's vehicle sales have surpassed the 10-million barrier -- consolidating their position as the number-one auto market in the world. As a result, investors are flocking to the sector. In fact, I know investors who purchased Boyd Gaming Corporation (NYSE: BYD) -- thinking they were buying the Chinese automaker that Warren Buffett made famous: BYD Company! But what all these investors are missing is that domestic Chinese automakers aren't the best way to play this opportunity. more...

Improving Jobs Situation in China

China has created some 7.6 million new jobs in the first eight months of this year -- putting the country fully on-track to surpass their full-year employment target! On the flip side, the U.S. has lost some 7.3 million jobs since the recession began. So, though the U.S. employment data isn't currently weighing too heavily on the market, the long-term effects will be very damaging. For now, our best investment bet is in China, taking advantage of their dramatic growth and speedy economic recovery. more...

Buy This Play on China's Swiftly-Growing Pharmaceutical Industry

The Chinese government's goal is to provide basic universal healthcare for its entire population -- all 1.3 billion -- by 2020. As a result, the market value of China's pharmaceutical market is expected to jump to about $120 billion by 2020. So to take advantage of this dominant and growing market trend, an excellent trade right now is the leading supplier of traditional Chinese medicine. Shares recently pulled back, making now a perfect time to load up before the next leg up! more...


Sponsored Links

Sign Up for Asia Edge
Sign Up for China Strategy
Sign Up for Inside China Dispatch

Thank you for your terrific initial advice. I subscribed on 12/26/05 and bought positions in FMCN, TOMO, and MOT the next day on the 27th. At the end of today, only two weeks later, I have gained 36.37% with FMCN, 8.71% with TOMO, and 4.23% with MOT. Granted that we have been in a rally, but gains like that in only 14 days are spectacular. I also appreciate your having been rapidly on the ball with your analysis of the PD debacle today -- I was wondering whether to buy based on your initial recommendation, and held off to see if you would comment. I'm glad I did.

J. Baird
Orleans, MA